retatrutide glp-1 gip glucagon receptor agonist triple Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight Why Retatrutide is different 👇

More details coming soon

If youre seeing positive resultssuch as a steady reduction in weight, improved appetite control, and better blood sugar managementyou may be encouraged to continue treatment for as long as these benefits persist

Factors such as patient preferences, frequency of dosing, comorbidities, and the primary goals of treatment whether focused on glycemic control, weight loss, or a combination of both play pivotal roles in guiding healthcare professionals and patients towards the most suitable therapeutic option

The right answer is patient-specific

Scientific References Semaglutide | Drugs - BNF - NICE

In recent years peptides have become widely known through the blockbuster success of GLP-1 medications, which the FDA has approved for treating obesity and diabetes